
Pharma R&D Spending 2026: R&D as % of Revenue, Top 25 Drugmakers
A 2026 analyst report ranking the top 25 drugmakers by R&D spending and R&D intensity, with PhRMA, Deloitte, and IQVIA benchmarks, five case studies, and AI's impact on pharma R&D.
IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

A 2026 analyst report ranking the top 25 drugmakers by R&D spending and R&D intensity, with PhRMA, Deloitte, and IQVIA benchmarks, five case studies, and AI's impact on pharma R&D.

A 2026 guide to building an AI roadmap for biotech: data readiness, use-case sequencing, FDA/EMA and EU AI Act governance, talent, and 5 named case studies including Roche, Novo Nordisk, and Insilico Medicine.

Examine Amgen's phased enterprise AI rollout to 20,000 employees. Learn about the Microsoft Copilot pilot, security guardrails, and AI adoption metrics.
© 2026 IntuitionLabs. All rights reserved.